SciTransfer
Moore4Medical · Project

Open Platforms to Get Medical Devices from Lab to Market Faster and Cheaper

healthPilotedTRL 6
moore4medical.eu

Getting a new medical device from a lab idea to something a doctor can actually use takes forever — often 10+ years. Moore4Medical brought together 65 partners led by Philips to build shared technology platforms that multiple companies can plug into, like building blocks for medical devices. Think of it like how smartphone components (screens, chips, sensors) became standardized so new phone models could launch faster. They built working demos of organ-on-chip systems, smart drug testing plates, an ultrasound-powered bone fracture monitor, and a nerve-stimulating implant — all designed to cut development time and cost for the next generation of medical electronics.

By the numbers
65
consortium partners across the project
12
countries represented in the consortium
38
industry partners involved in development
21
SMEs participating in the project
9
demonstration deliverables completed
58%
industry ratio in the consortium
The business problem

What needed solving

Medical device innovation moves far too slowly compared to consumer electronics — taking years longer and costing significantly more to get from concept to market. Every MedTech company essentially reinvents the wheel on core components like microfluidics, sensors, and implant electronics, because there are no shared technology platforms like those that accelerated the smartphone industry. This fragmentation drives up costs, extends timelines, and keeps potentially life-saving devices stuck in the 'Valley of Death' between lab and bedside.

The solution

What was built

The project built and demonstrated 9 concrete technology platforms: organ-on-chip devices integrated into smart well plate systems, high-definition electrophysiology multiwell plates, smart well plate lids with fluidic and electrical functionality, an ultrasound-powered fracture monitor, an inductively powered nerve-stimulating implant, and an end-to-end security and privacy platform for medical data. All were demonstrated in realistic settings with representative biological materials.

Audience

Who needs this

Pharma companies doing preclinical drug screening who want alternatives to animal testingMedical device startups needing pre-validated electronic and microfluidic building blocksOrthopedic device companies interested in wireless fracture monitoringNeurostimulation companies developing next-generation implantable therapiesClinical diagnostics companies building point-of-care testing platforms
Business applications

Who can put this to work

Pharmaceutical & Drug Development
enterprise
Target: Pharma companies or CROs doing preclinical drug testing

If you are a pharma company spending millions on animal testing and early-stage drug screening — this project built smart well plate platforms with organ-on-chip devices demonstrated in realistic cell culture settings. These platforms let you test drug candidates on human-tissue-mimicking chips instead of animals, potentially cutting preclinical costs and improving prediction accuracy before costly clinical trials.

MedTech & Medical Device Manufacturing
mid-size
Target: Medical device companies developing implantable or point-of-care products

If you are a medical device maker struggling with long development cycles — this project created open technology platforms specifically designed to help bridge the 'Valley of Death' between prototype and product. With 9 demonstrated prototypes including an ultrasound-powered fracture monitor and a nerve-stimulating implant, the platforms offer reusable building blocks so you don't have to reinvent every component from scratch.

Clinical Diagnostics
any
Target: Diagnostic equipment manufacturers or hospital lab technology providers

If you are a diagnostics company looking to build smarter point-of-care tools — this project demonstrated high-definition electrophysiology multiwell plates and smart well plate lids with integrated fluidic and electrical functionality. These 65-partner-validated platforms could accelerate your path from concept to a working diagnostic device by providing pre-validated electronic and microfluidic building blocks.

Frequently asked

Quick answers

What would it cost to access or license these technology platforms?

The project does not publish pricing or licensing terms for its open technology platforms. Since Philips Electronics leads the consortium with 38 industry partners involved, commercial licensing arrangements would need to be negotiated directly with the relevant platform owners. Contact the coordinator for specific terms.

Can these platforms scale to industrial production volumes?

The project objective explicitly targets 'medium to high volume markets' and uses an electronics industry platform approach designed for scale. With 38 industry partners and 21 SMEs already involved in development, the platforms were designed with manufacturing scalability in mind, though individual device applications may be at different maturity stages.

Who owns the IP and how is it licensed?

With 65 partners across 12 countries, IP ownership is distributed across the consortium. The project emphasizes 'open technology platforms,' suggesting a shared-access model, but specific IP terms vary by component. Philips as coordinator would be the first point of contact for licensing discussions.

How proven are these technologies — are they lab demos or ready for patients?

The project delivered 9 demonstration deliverables including organ-on-chip devices, smart well plates tested with representative cell cultures, a final ultrasound-powered fracture monitor, and a final nerve-stimulating implant. These are functional demonstrators validated in realistic settings, but regulatory approval for patient use would still be required.

What regulatory pathway would these devices need?

Medical devices require CE marking (MDR in Europe) or FDA clearance. The project includes an end-to-end security and privacy platform demonstration, indicating regulatory requirements like data protection were considered during development. However, each specific device application would need its own regulatory pathway.

Can these platforms integrate with our existing R&D infrastructure?

The platforms were specifically designed as 'open' technology platforms usable by multiple users for multiple applications. The smart well plate system demonstrates both fluidic and electrical functionality integration, and the HD electrophysiology multiwell plate shows compatibility with standard lab formats. Integration specifics would depend on your existing setup.

What kind of support is available for adopting these platforms?

The consortium includes 13 universities and 14 research organizations alongside 38 industry partners, providing a deep knowledge base. Based on available project data, ongoing support arrangements would need to be discussed with the relevant platform developers within the consortium.

Consortium

Who built it

This is one of the largest medical device consortia in Horizon 2020 with 65 partners across 12 countries, led by Philips Electronics — a global MedTech leader. The consortium is heavily industry-weighted at 58% (38 industry partners), with 21 SMEs bringing specialized capabilities alongside 13 universities and 14 research organizations providing scientific depth. The strong Dutch-German-Italian axis reflects Europe's MedTech manufacturing heartland. For a business considering these technologies, the high industry ratio and Philips leadership signal that commercial viability was a design priority, not an afterthought. The 21 SMEs in the consortium also represent a ready ecosystem of specialized suppliers and integration partners.

How to reach the team

Philips Electronics Nederland BV (Netherlands) — contact through their MedTech or open innovation division

Order a report on this consortiumSee PHILIPS ELECTRONICS NEDERLAND BV profile →
Next steps

Talk to the team behind this work.

Want to explore licensing one of the 9 demonstrated platforms or connect with a specific consortium partner? SciTransfer can identify the right contact and arrange an introduction.

Order a report on this topicMore in Health & Biomedical
More in Health & Biomedical
See all Health & Biomedical projects →
Automated Allergy Test Covering All Allergens in One Run, Ready to Ship
AllergyExplorer
Open →
Lab-Sized 3D Cell Microscope Replaces 12-Month Waits at Giant Synchrotron Facilities
LICENT
Open →
Blood Test Platform That Catches Rare Diseases Early Using AI-Powered Diagnostics
METAdiag
Open →